OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals

NCT ID: NCT05526092

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-12

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of this research entity is to reveal the holistic health impact of oats in metabolically challenged individuals in a 6-week intervention, compared to that of rice. This is achieved by investigation of the plasma lipids, plasma antioxidant status, fecal microbiota and fecal bile acids. Additionally the effect of the 6-week diet on posptprandial glycemia and postprandial satiety and vitality are investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aims in this 6-week randomised, single-blinded clinical trial, including a postprandial study at the 6 week time point, with metabolically challenged volunteers on oat-rich low-gluten diet, are to:

1. Compare effect of oat and rice rich diets to blood lipid and glucose status, perceived gut well-being and diet quality.
2. Investigate changes in microbiota, SCFAs, plasma antioxidant status and inflammation markers resulting from consumption of oat or rice rich low gluten diets.
3. Examine the impact of the oat and rice rich gluten free diet on the change in metabolite profiles in blood.
4. Find out the long-term effects of oat and rice consumption on recovery and vitality by modulating the gut-brain axis and measured with neuropsychological testing and using tryptophan metabolites as markers.
5. Discover how the long-term consumption of oats and rice and their possible alterations in gut microbiota affect subsequent postprandial glycaemia and response of microbiota to the meal (as seen in plasma SCFAs).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High Cholesterol/Hyperlipidemia High Blood Pressure Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oat-rich and low-gluten diet

Participants will consume oats and oat products and follow low-gluten diet for 6 weeks.

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

Changes in metabolism, microbiota, vitality and comprehensive health after 6 week consumption of oat / rice.

Rice-rich and low-gluten diet

Participants will consume rice and rice products and follow low-gluten diet for 6 weeks.

Group Type PLACEBO_COMPARATOR

Dietary intervention

Intervention Type OTHER

Changes in metabolism, microbiota, vitality and comprehensive health after 6 week consumption of oat / rice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary intervention

Changes in metabolism, microbiota, vitality and comprehensive health after 6 week consumption of oat / rice.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Commits to follow low-gluten diet for 6 weeks
* 30 - 68 years of age
* BMI \> 25 kg/m\^2
* High cholesterol AND/OR Hypertension

Exclusion Criteria

* Regular medication that can affect the gut
* Pregnancy or lactation
* Recent course of antibiotics (less than 3 months prior to the study)
Minimum Eligible Age

30 Years

Maximum Eligible Age

68 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Turku

OTHER

Sponsor Role lead

University of Eastern Finland

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kaisa Linderborg

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Food Sciences, Department of Life Technologies, University of Turku

Turku, Turku, Finland

Site Status

Institute of Public Health and Clinical Nutrition, University of Eastern Finland

Kuopio, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OGB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Barley Bread and Metabolic Disease
NCT02867215 COMPLETED NA
Measuring Daily Grain Intake Study
NCT04104581 COMPLETED NA